Quantcast
Browsing all 5442 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Merck Serono to Broaden Its General Medicines Portfolio in Emerging Markets...

  DARMSTADT, Germany Merck Serono, the biopharmaceutical division of Merck, today announced the establishment of a long-term strategic partnership with Lupin Limited (Lupin), India. Lupin will support...

View Article


Image may be NSFW.
Clik here to view.

CSL Behring Announces Last Patient Treated in Phase III Study of Fibrinogen...

  FLORENCE, Italy CSL Behring announced today that the last patient has been treated as part of the REPLACE (Randomized Evaluation of fibrinogen versus PLACEbo in complex cardiovascular surgery) Phase...

View Article


Image may be NSFW.
Clik here to view.

FUJIFILM VisualSonics、世界分子イメージング学会の年次総会にて、VEVO® 3100を発表。 前臨床画像検査の、究極のあり方を実現。

  カナダ、トロント発 (ブース番号510)FUJIFILM SonoSite, Inc.の子会社であるFUJIFILM VisualSonics Inc. は、前臨床研究に特に焦点を絞った高解像度のリアルタイム生体内ミクロイメージング システムの世界的リーダーの1つです。そのFUJIFILM...

View Article

Image may be NSFW.
Clik here to view.

Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab

  WHITEHOUSE STATION, N.J., and MUMBAI, India Merck & Co., Inc., (NYSE:MRK), known as MSD outside the United States and Canada, and Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg:...

View Article

Image may be NSFW.
Clik here to view.

Wells Fargo Lights Up Diwali by Helping Give Children a Lifetime of Smiles

  SAN FRANCISCO Wells Fargo & Company (NYSE:WFC) is lighting up Diwali with community celebrations and partnerships throughout the country. In addition to supporting Diwali Festivals and other...

View Article


Image may be NSFW.
Clik here to view.

FUJIFILM VisualSonics Unveils the Ultimate Pre-Clinical Imaging Experience...

  TORONTO (Booth #510) – FUJIFILM VisualSonics Inc., a world leader in real time, in vivo, high-resolution micro-imaging systems designed specifically for pre-clinical research and subsidiary of...

View Article

Image may be NSFW.
Clik here to view.

巴伐利亚州红十字会选用LIFEPAK® 监护仪/除颤仪

  华盛顿州雷德蒙德 (美国商业资讯) –德国巴伐利亚州救护车服务宣布,其急诊反应车队将配备Physio-Control出品的监护仪/除颤仪。该急救机构是西欧最大的急救机构之一,日均急诊呼叫超过3,000次,占巴伐利亚全州急救服务量的近80%。该机构将采购多达450台Physio-Control LIFEPAK 15和150 LIFEPAK...

View Article

Image may be NSFW.
Clik here to view.

Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI...

  HENDERSON, Nev. & ROCKVILLE, Md. Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in...

View Article


Image may be NSFW.
Clik here to view.

United Health Products Inc. Announces St John Ambulance to Implement Hemostyp...

  HENDERSON, Nev. United Health Products, Inc. (OTCQB: UEEC) announced that its Australian Distributor Critical Health, in conjunction with their key partner, has secured the first order from St John...

View Article


Image may be NSFW.
Clik here to view.

バイエルン赤十字がLIFEPAK®モニター/除細動器を選定

  米ワシントン州レドモンド (ビジネスワイヤ) — ドイツのRettungsdienst Bayernは、救急車にフィジオコントロールのモニター/除細動器を装備すると発表しました。同救急車サービスは西欧有数の規模を誇り、1日に平均3000件以上の救急通報に応じ、バイエルンの救急車サービスの約80パーセントを提供しています。Rettungsdienst...

View Article

Image may be NSFW.
Clik here to view.

Institut Pasteur de Montevideo, Genomic Medicine Institute-Seoul National...

  SEOUL, South Korea Institut Pasteur de Montevideo (Uruguay), Genomic Medicine Institute- Seoul National University (GMI-SNU, South Korea) and Macrogen Inc. ( KRX 038290) (South Korea) have announced...

View Article

Image may be NSFW.
Clik here to view.

Telormedix Granted European Patent for Vesimune

  BIOGGIO, Switzerland Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and infectious diseases, announced today that it has been granted the...

View Article

Image may be NSFW.
Clik here to view.

EHOB Opens Company’s First International Office in China

  INDIANAPOLIS EHOB, a leading provider of affordable products effective in the prevention and treatment of pressure ulcers, announces today the opening of its first international office in China....

View Article


Image may be NSFW.
Clik here to view.

NeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of...

  WALTHAM, Mass. NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29th Annual Meeting of...

View Article

Image may be NSFW.
Clik here to view.

Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing...

  DEERFIELD, Ill. & CAMBRIDGE, Mass. Baxter International Inc. (NYSE:BAX) and Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today jointly announced an exclusive license and collaboration agreement...

View Article


Image may be NSFW.
Clik here to view.

NCKU Research Team Reveals Key Mechanism in Lung Cancer

  TAINAN, Taiwan Lung cancer remains one of the most common and malignant cancers worldwide. A Tainan-based research team from National Cheng Kung University (NCKU) has discovered Rab37, a protein in...

View Article

Image may be NSFW.
Clik here to view.

Blaze Bioscience Announces Initiation of Phase 1b Brain Cancer Program for...

  SEATTLE Blaze Bioscience, Inc., a biotechnology company focused on guided cancer therapy, announced today that the company has received clearance from the United States Food and Drug Administration...

View Article


Image may be NSFW.
Clik here to view.

PharmaEngine and Merrimack Amend MM-398 License Agreement

  TAIPEI, Taiwan PharmaEngine, Inc. (TWO: 4162), announced today that the company has signed an Amendment to its License Agreement of MM-398 (aka PEP02, nanoliposomal irinotecan injection, nal-IRI)...

View Article

Image may be NSFW.
Clik here to view.

Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA...

  BOTHELL, Wash. & OSAKA, Japan Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received...

View Article

Image may be NSFW.
Clik here to view.

Infraredx Receives Regulatory Approval of TVC Imaging System in Japan

  BURLINGTON, Mass. Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that its first-in-class, dual-modality...

View Article
Browsing all 5442 articles
Browse latest View live